Extracellular vesicles (EVs) derived from senescent hepatocytes have been identified as significant promoters of tumor metastasis in aged mice. This study reveals that aged liver tissue exhibits increased expression of P2X purinoceptor 7 (P2RX7), leading to enhanced EV biogenesis. The research highlights that EVs encapsulating specific miRNAs—miR-25, miR-92a, miR-30c, and miR-30d—can circulate and reach primary tumors, thereby increasing their invasiveness and metastatic potential. Clinical samples from older patients corroborate these findings, showing reduced expression of target genes PTEN and LATS2, alongside enhanced epithelial–mesenchymal transition in metastatic tumors.

The implications of these findings are profound, particularly in understanding the mechanistic links between aging and cancer progression. The study demonstrates that targeting cellular senescence with compounds like dasatinib and quercetin (D + Q), inhibiting P2RX7, or silencing the identified EV-associated miRNAs can significantly reduce metastasis in aged models. This suggests that the age-related secretory profile of senescent cells plays a critical role in promoting cancer metastasis, potentially offering new avenues for therapeutic intervention.

This research shifts the paradigm in cancer biology by emphasizing the role of senescent cell-derived EVs in tumor progression, particularly in the elderly population. As such, it opens up new pathways for drug development targeting these mechanisms, which could lead to more effective treatments for metastatic cancers in older adults. The findings also underscore the importance of considering age-related factors in cancer research, potentially accelerating the timelines for developing targeted therapies that address the unique challenges posed by aging in cancer patients.

Source: nature.com